Top View
- Posters: 1796-P to 1801-P), See Page 19
- Fine Test Your Good Research Partner
- A Acetaldehyde Acetate
- Hormone Responsive Genes Involved in Osteoporosis in Post- Menopausal Women
- Progress of Alzheimer's Disease Related Glucose Metabolism
- University of Nevada, Reno Effects of Asprosin on Steroidogeneses Of
- Is Asprosin, a Real Actor of Diabetes Etiopathology? Kader Ugur1, Meltem Yardim2 and Suleyman Aydin2
- Asprosin: a Novel Player in Metabolic Diseases
- Diabetes Mellitus: Disorder of Cellular Dysfunction Due to Lack of Entry Into Cell of Glucose
- Research Article Serum Levels of Asprosin, a Novel Adipokine, Are Significantly Lowered in Patients with Acromegaly
- Asprosin and Effects on Glucose Metabolism
- Diabetes and Obesity - Arterial Disease) Complications
- Mechanisms of Adiponectin Action
- Asprosin—A Fasting-Induced, Glucogenic, and Orexigenic Adipokine As a New Promising Player. Will It Be a New Factor in The
- Circulating Asprosin Concentrations Are Increased in Type 2 Diabetes Mellitus and Independently Associated with Fasting Glucose and Triglyceride T
- The Asprosin–OLFR734 Module Regulates Appetitive Behaviors Yang Liu1, Aijun Long1,Liqunchen1, Liangjie Jia1 and Yiguo Wang 1
- Flourous Metabolically Stable Peptide Analogs
- Energy Regulation Mechanism and Therapeutic Potential of Asprosin
- Obesity Algorithm®
- Drosophila PDGF/VEGF Signaling from Muscles to Hepatocyte-Like
- Focus on the Galanin Family of Peptides
- Mental Health Effects of Endocrine Dysfunction: Symptoms, Assessment and Treatment Strategies
- Decreased Blood Asprosin in Hyperglycemic Menopausal Women As a Result of Whole-Body Cryotherapy Regardless of Metabolic Syndrome
- Effect of Sodium-Glucose Co-Transporter-2 Inhibitors on the Levels of Serum Asprosin in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
- Research and Prospect of Peptides for Use in Obesity Treatment (Review)
- Asprosin Neutralizing Antibodies As a Treatment for Metabolic Syndrome Authors